Farmacotherapy of osteoporosis: calcium, vitamin D, hormonal treatments, selective estrogen receptor modulators and strontium ranelate

Abstract

This review examines the clinical data available to date on pharmacological properties of calcium and vitmain D supplements, hormone therapy and tibolone, selective estrogen receptors modulators, and strontium ranelate in prevention in treatment of osteoporosis, their effects and contraindications.

Keywords

• aminobisphosphonates
• estrogen
• osteoporosis
• SERMs
• strontium ranelate
• tibolone